vs
STANDARD BIOTOOLS INC.（LAB）与TRIO-TECH INTERNATIONAL（TRT）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是TRIO-TECH INTERNATIONAL的1.2倍（$19.6M vs $15.6M），TRIO-TECH INTERNATIONAL净利率更高（0.8% vs -177.4%，领先178.2%），TRIO-TECH INTERNATIONAL同比增速更快（81.6% vs -11.5%），TRIO-TECH INTERNATIONAL自由现金流更多（$-152.0K vs $-23.1M），过去两年TRIO-TECH INTERNATIONAL的营收复合增速更高（22.7% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
Trio-Tech International是一家全球半导体测试与老化解决方案供应商，同时面向航空航天、消费电子等领域客户提供电子元件专业制造服务，业务覆盖北美、亚洲、欧洲多地，可交付定制化可靠性测试系统及配套支持服务。
LAB vs TRT — 直观对比
损益表 — Q3 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $15.6M |
| 净利润 | $-34.7M | $126.0K |
| 毛利率 | 48.5% | 16.0% |
| 营业利润率 | -168.5% | 0.6% |
| 净利率 | -177.4% | 0.8% |
| 营收同比 | -11.5% | 81.6% |
| 净利润同比 | -28.8% | -75.1% |
| 每股收益（稀释后） | $-0.09 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | — | $15.6M | ||
| Q3 25 | $19.6M | $15.5M | ||
| Q2 25 | $21.8M | $10.7M | ||
| Q1 25 | $40.8M | $7.4M | ||
| Q4 24 | — | $8.6M | ||
| Q3 24 | $22.1M | $9.8M | ||
| Q2 24 | $22.5M | $9.7M | ||
| Q1 24 | $45.5M | $10.4M |
| Q4 25 | — | $126.0K | ||
| Q3 25 | $-34.7M | $77.0K | ||
| Q2 25 | $-33.5M | $183.0K | ||
| Q1 25 | $-26.0M | $-495.0K | ||
| Q4 24 | — | $507.0K | ||
| Q3 24 | $-26.9M | $-236.0K | ||
| Q2 24 | $-45.7M | $243.0K | ||
| Q1 24 | $-32.2M | $70.0K |
| Q4 25 | — | 16.0% | ||
| Q3 25 | 48.5% | 16.7% | ||
| Q2 25 | 48.8% | 24.6% | ||
| Q1 25 | 48.4% | 26.8% | ||
| Q4 24 | — | 25.7% | ||
| Q3 24 | 54.9% | 23.7% | ||
| Q2 24 | 46.1% | 27.5% | ||
| Q1 24 | 53.1% | 26.0% |
| Q4 25 | — | 0.6% | ||
| Q3 25 | -168.5% | 0.3% | ||
| Q2 25 | -118.1% | 4.4% | ||
| Q1 25 | -80.8% | -4.6% | ||
| Q4 24 | — | -0.0% | ||
| Q3 24 | -120.9% | 1.4% | ||
| Q2 24 | -134.5% | 3.7% | ||
| Q1 24 | -132.2% | 0.6% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | -177.4% | 0.5% | ||
| Q2 25 | -153.7% | 1.7% | ||
| Q1 25 | -63.8% | -6.7% | ||
| Q4 24 | — | 5.9% | ||
| Q3 24 | -122.0% | -2.4% | ||
| Q2 24 | -203.3% | 2.5% | ||
| Q1 24 | -70.6% | 0.7% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | $-0.09 | $0.02 | ||
| Q2 25 | $-0.09 | $0.11 | ||
| Q1 25 | $-0.07 | $-0.12 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | $-0.07 | $-0.06 | ||
| Q2 24 | $-0.12 | $0.05 | ||
| Q1 24 | $-0.27 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $16.5M |
| 总债务越低越好 | — | $581.0K |
| 股东权益账面价值 | $399.7M | $33.5M |
| 总资产 | $539.6M | $45.7M |
| 负债/权益比越低杠杆越低 | — | 0.02× |
8季度趋势，按日历期对齐
| Q4 25 | — | $16.5M | ||
| Q3 25 | $129.4M | $17.4M | ||
| Q2 25 | $158.6M | $16.7M | ||
| Q1 25 | $150.9M | $17.6M | ||
| Q4 24 | — | $16.5M | ||
| Q3 24 | $210.6M | $15.5M | ||
| Q2 24 | $269.8M | $16.5M | ||
| Q1 24 | $287.1M | $17.0M |
| Q4 25 | — | $581.0K | ||
| Q3 25 | — | $622.0K | ||
| Q2 25 | — | $684.0K | ||
| Q1 25 | — | $729.0K | ||
| Q4 24 | — | $782.0K | ||
| Q3 24 | $55.2M | $923.0K | ||
| Q2 24 | $55.1M | $874.0K | ||
| Q1 24 | $55.0M | $984.0K |
| Q4 25 | — | $33.5M | ||
| Q3 25 | $399.7M | $34.1M | ||
| Q2 25 | $424.5M | $34.0M | ||
| Q1 25 | $454.6M | $32.3M | ||
| Q4 24 | — | $31.8M | ||
| Q3 24 | $489.3M | $33.1M | ||
| Q2 24 | $510.3M | $31.3M | ||
| Q1 24 | $577.3M | $31.2M |
| Q4 25 | — | $45.7M | ||
| Q3 25 | $539.6M | $47.4M | ||
| Q2 25 | $557.0M | $41.1M | ||
| Q1 25 | $579.6M | $40.0M | ||
| Q4 24 | — | $39.8M | ||
| Q3 24 | $681.5M | $42.9M | ||
| Q2 24 | $708.7M | $42.5M | ||
| Q1 24 | $777.7M | $43.1M |
| Q4 25 | — | 0.02× | ||
| Q3 25 | — | 0.02× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 0.11× | 0.03× | ||
| Q2 24 | 0.11× | 0.03× | ||
| Q1 24 | 0.10× | 0.03× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $134.0K |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $-152.0K |
| 自由现金流率自由现金流/营收 | -118.1% | -1.0% |
| 资本支出强度资本支出/营收 | 4.5% | 1.8% |
| 现金转化率经营现金流/净利润 | — | 1.06× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $137.0K |
8季度趋势，按日历期对齐
| Q4 25 | — | $134.0K | ||
| Q3 25 | $-22.2M | $933.0K | ||
| Q2 25 | $-20.7M | $-664.0K | ||
| Q1 25 | $-30.3M | $781.0K | ||
| Q4 24 | — | $2.1M | ||
| Q3 24 | $-27.9M | $-1.9M | ||
| Q2 24 | $-39.0M | $199.0K | ||
| Q1 24 | $-62.5M | $1.2M |
| Q4 25 | — | $-152.0K | ||
| Q3 25 | $-23.1M | $887.0K | ||
| Q2 25 | $-22.6M | $-1.2M | ||
| Q1 25 | $-35.3M | $623.0K | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | $-30.1M | $-1.9M | ||
| Q2 24 | $-41.0M | $-135.0K | ||
| Q1 24 | $-63.3M | $1.1M |
| Q4 25 | — | -1.0% | ||
| Q3 25 | -118.1% | 5.7% | ||
| Q2 25 | -103.6% | -11.4% | ||
| Q1 25 | -86.6% | 8.4% | ||
| Q4 24 | — | 22.4% | ||
| Q3 24 | -136.4% | -19.7% | ||
| Q2 24 | -182.2% | -1.4% | ||
| Q1 24 | -138.9% | 10.6% |
| Q4 25 | — | 1.8% | ||
| Q3 25 | 4.5% | 0.3% | ||
| Q2 25 | 8.7% | 5.2% | ||
| Q1 25 | 12.4% | 2.1% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | 10.2% | 0.7% | ||
| Q2 24 | 8.6% | 3.4% | ||
| Q1 24 | 1.7% | 0.5% |
| Q4 25 | — | 1.06× | ||
| Q3 25 | — | 12.12× | ||
| Q2 25 | — | -3.63× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.16× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.82× | ||
| Q1 24 | — | 16.44× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
TRT
| Semiconductor Backend Solutions | $12.4M | 79% |
| Industrial Electronics | $3.3M | 21% |
